Page last updated: 2024-10-24

carmustine and Disseminated Intravascular Coagulation

carmustine has been researched along with Disseminated Intravascular Coagulation in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schenk, H1
Fereberger, W1
Siddiqi, TS1
Buchheit, WA1

Other Studies

2 other studies available for carmustine and Disseminated Intravascular Coagulation

ArticleYear
[Acute disorders of hemostasis].
    Wiener medizinische Wochenschrift (1946), 1984, Jul-31, Volume: 134, Issue:13-14

    Topics: Antithrombin III; Autoimmune Diseases; Blood Coagulation Disorders; Blood Platelets; Carmustine; Dis

1984
Disseminated intravascular coagulation--a complication of 1,3-bis(2-chlorethyl)-nitrosourea therapy.
    Surgical neurology, 1983, Volume: 19, Issue:2

    Topics: Adult; Astrocytoma; Brain Neoplasms; Carmustine; Disseminated Intravascular Coagulation; Female; Hum

1983